Structure Therapeutics Inc. (GPCR) earnings
GPCR earnings moved a median of -2.00% by the close. Quarterly and annual GPCR reports and results, each read against the price at its own news timestamp. Back to the GPCR overview →
24 measured GPCR earnings events.
Where these GPCR earnings landedvs 24 measured GPCR earnings reactions
| Middle 50% of GPCR earnings reactions | -3.25% to +1.71% |
|---|---|
| Median reaction (to close) | -2.00% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 GPCR earnings events with a measured close landed between -3.25% and +1.71%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.51% | +1.50% | |
| Structure Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights | Press release | -0.51% | +1.50% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.99% | -1.45% | |
| Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights | Press release | -0.99% | -1.45% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.54% | +2.46% | |
| Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights | Press release | +2.54% | +2.46% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.97% | -1.79% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -1.22% | -2.55% | |
| Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights | Press release | -1.22% | -2.55% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -2.37% | -8.42% | |
| Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights | Press release | -2.37% | -8.42% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -0.30% | -4.05% | |
| Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights | Press release | -0.30% | -4.05% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.26% | +2.37% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -3.79% | +4.69% | |
| Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights | Press release | -3.79% | +4.69% | |
| Form 10-Q Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -4.03% | -6.12% | |
| Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights | Press release | -4.03% | -6.12% | |
| Form 10-Q Structure Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.38% | -2.98% | |
| Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights | Press release | +2.38% | -2.98% | |
| Form 10-K Structure Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.04% | +0.19% | |
| Form 10-Q Structure Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.51% | -2.21% | |
| Form 10-Q/A Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.51% | -2.21% | |
| Form 10-Q/A Structure Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +4.48% | +14.97% |
Keep exploring
More GPCR: analyst actions → · SEC filings → · GPCR overview →